Derveaux et al. improved metabolite quantification and the metabolite fingerprinting of lung cancer by adding a more accurate internal standard (MA) in combination with an HSA-binding competitor TSP and using a stronger NMR magnetic field strength [20]. The gene discussed is ALB; the disease is lung carcinoma.